BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 16315292)

  • 21. [Treatment for hepatocellular carcinoma].
    Urabe T; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():489-93. PubMed ID: 11761999
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver tumors and loco-regional therapy.
    Vogel W
    Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
    [No Abstract]   [Full Text] [Related]  

  • 23. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial.
    Bang MH; Van Riep T; Thinh NT; Song le H; Dung TT; Van Truong L; Van Don L; Ky TD; Pan D; Shaheen M; Ghoneum M
    Anticancer Res; 2010 Dec; 30(12):5145-51. PubMed ID: 21187503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expert consensus on standardization of the management of primary liver cancer].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):403-10. PubMed ID: 19645134
    [No Abstract]   [Full Text] [Related]  

  • 25. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?
    Moreno P; Jaurrieta E; Figueras J; Benasco C; Rafecas A; Fabregat J; Torras J; Casanovas T; Casais L
    Transplant Proc; 1995 Aug; 27(4):2296-8. PubMed ID: 7652813
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
    Majno P; Giostra E; Mentha G
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S27-35. PubMed ID: 17969086
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.
    Duvoux C; Cherqui D; Van Nhieu JT; Vavasseur D; Zafrani ES; Mathieu D; Fagniez PL; Dhumeaux D
    Transplant Proc; 1994 Dec; 26(6):3572-3. PubMed ID: 7527981
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of hepatocellular carcinoma in cirrhosis: locoregional therapies for bridging to liver transplant.
    Lee FT
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S24-6. PubMed ID: 17969066
    [No Abstract]   [Full Text] [Related]  

  • 29. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 30. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic prediction and treatment strategy in hepatocellular carcinoma.
    Bruix J; Llovet JM
    Hepatology; 2002 Mar; 35(3):519-24. PubMed ID: 11870363
    [No Abstract]   [Full Text] [Related]  

  • 32. Comments on "Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?".
    Lee MW
    Radiology; 2010 Feb; 254(2):633; author reply 634. PubMed ID: 20093536
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of hepatectomy-predominant treatment on stage III A hepatocellular carcinoma: a report of 108 cases].
    Zhong C; Guo RP; Chen MS; Wei W; Chen ZY
    Ai Zheng; 2009 Mar; 28(3):274-8. PubMed ID: 19619442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical treatment for small hepatocellular carcinoma].
    Eguchi S; Furui J; Yanaga K; Kanematsu T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():511-5. PubMed ID: 11762003
    [No Abstract]   [Full Text] [Related]  

  • 35. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
    Sudan D; Sudan R; Schafer D; Langnas A
    Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
    [No Abstract]   [Full Text] [Related]  

  • 36. Interventional therapies for hepatocellular carcinoma.
    Willatt JM; Francis IR; Novelli PM; Vellody R; Pandya A; Krishnamurthy VN
    Cancer Imaging; 2012 Apr; 12(1):79-88. PubMed ID: 22487698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract]   [Full Text] [Related]  

  • 39. The liver with carcinoma: resect or remove?
    Jones DM
    Am J Gastroenterol; 1992 Jun; 87(6):803-4. PubMed ID: 1317096
    [No Abstract]   [Full Text] [Related]  

  • 40. [Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
    Lang H; Ricke J; Schlaak J
    Dtsch Med Wochenschr; 2013 Sep; 138(36):1780-4. PubMed ID: 23943578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.